Sinopharm Group Co Ltd
OTC:SHTDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinopharm Group Co Ltd
OTC:SHTDF
|
CN |
|
CoStar Group Inc
F:RLG
|
US |
|
K
|
Kering SA
XHAM:PPX
|
FR |
|
Valeo SE
OTC:VLEEF
|
FR |
|
Shell PLC
F:R6C0
|
UK |
|
E
|
EssilorLuxottica SA
DUS:ESL
|
FR |
|
S
|
Seven & i Holdings Co Ltd
DUS:S6M
|
JP |
|
E
|
Eli Lilly and Co
DUS:LLY
|
US |
|
P
|
Palo Alto Networks Inc
F:5AP
|
US |
|
C
|
Crane Co
NYSE:CR
|
US |
|
C
|
COSCO Shipping Holdings Co Ltd
XMUN:C6G
|
CN |
|
B
|
BNP Paribas SA
XMUN:BNP
|
FR |
|
J
|
Jasmine International PCL
SET:JAS
|
TH |
|
A
|
Apollo Medical Holdings Inc
F:3AM
|
US |
|
Triumph New Energy Co Ltd
F:LUG
|
CN |
|
Bell Food Group AG
SIX:BELL
|
CH |
|
C
|
Capital One Financial Corp
SWB:CFX
|
US |
Wall St Price Targets
SHTDF Price Targets Summary
Sinopharm Group Co Ltd
According to Wall Street analysts, the average 1-year price target for SHTDF is 3.08 USD with a low forecast of 2.48 USD and a high forecast of 3.76 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SHTDF's stock price target?
Price Target
3.08
USD
According to Wall Street analysts, the average 1-year price target for SHTDF is 3.08 USD with a low forecast of 2.48 USD and a high forecast of 3.76 USD.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
26%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 26%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 9%.
